- Home
- DMA vs FORA Comparison
DMA vs FORA Comparison
Compare DMA & FORA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DMA
- FORA
- Stock Information
- Founded
- DMA 2011
- FORA 2014
- Country
- DMA United States
- FORA United States
- Employees
- DMA N/A
- FORA N/A
- Industry
- DMA Trusts Except Educational Religious and Charitable
- FORA Computer Software: Prepackaged Software
- Sector
- DMA Finance
- FORA Technology
- Exchange
- DMA Nasdaq
- FORA Nasdaq
- Market Cap
- DMA 72.0M
- FORA 62.7M
- IPO Year
- DMA N/A
- FORA N/A
- Fundamental
- Price
- DMA $8.46
- FORA $1.99
- Analyst Decision
- DMA
- FORA Strong Buy
- Analyst Count
- DMA 0
- FORA 1
- Target Price
- DMA N/A
- FORA $5.00
- AVG Volume (30 Days)
- DMA 34.6K
- FORA 27.4K
- Earning Date
- DMA 01-01-0001
- FORA 05-16-2025
- Dividend Yield
- DMA 2.04%
- FORA N/A
- EPS Growth
- DMA N/A
- FORA N/A
- EPS
- DMA N/A
- FORA N/A
- Revenue
- DMA N/A
- FORA $20,153,263.00
- Revenue This Year
- DMA N/A
- FORA $13.31
- Revenue Next Year
- DMA N/A
- FORA N/A
- P/E Ratio
- DMA N/A
- FORA N/A
- Revenue Growth
- DMA N/A
- FORA N/A
- 52 Week Low
- DMA $4.78
- FORA $1.85
- 52 Week High
- DMA $8.00
- FORA $4.03
- Technical
- Relative Strength Index (RSI)
- DMA 57.65
- FORA 49.09
- Support Level
- DMA $8.25
- FORA $1.93
- Resistance Level
- DMA $8.54
- FORA $2.11
- Average True Range (ATR)
- DMA 0.20
- FORA 0.13
- MACD
- DMA 0.05
- FORA 0.00
- Stochastic Oscillator
- DMA 79.30
- FORA 34.75
About DMA Destra Multi-Alternative Fund
Destra Multi-Alternative Fund is a non-diversified, closed-end management investment company that operates as an interval fund with a continuous offering of fund shares. The investment objective of the fund is to seek returns from capital appreciation and income with an emphasis on income generation.
About FORA Forian Inc.
Forian Inc provides a suite of Software, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer, and provider segments, as well as cannabis dispensaries, manufacturers, and cultivators.